Edge Medical Deploys World's First Integrated Single-Port and Multi-Port Surgical Robot MSP2000 at Hungary's National Institute of Oncology

A Chinese surgical-robot maker has planted its flag in one of Europe's most prestigious cancer centers, marking the first time a "single-port and multi-port integrated" robotic surgery platform has been deployed outside China—and signaling a shift in a market long dominated by Western incumbents.

Shenzhen Jingfeng Medical Technology Co., Ltd., known commercially as Edge Medical, recently completed the installation of its MSP2000 system at Hungary's National Institute of Oncology (NIO), the country's largest and most authoritative cancer diagnosis, treatment and research institution. The system is now in clinical use.

The deployment makes Edge Medical the second laparoscopic surgical-robot brand to enter the Hungarian market, and the first overseas installation of its integrated single-port/multi-port product form. For a sector where Intuitive Surgical's da Vinci system has long set the standard, the move represents a notable challenge to the established order.

A High-Stakes Beachhead in Central Europe

The choice of venue is deliberate. Founded in 1952, NIO serves as Hungary's national reference center for oncology—coordinating the country's National Cancer Control Program, managing the National Cancer Registry, and setting standards for tumor diagnosis and treatment nationwide. It is also the only Comprehensive Cancer Center in Central and Eastern Europe certified by the Organisation of European Cancer Institutes (OECI), a designation that places it among a select group of elite cancer institutions on the continent.

NIO operates multiple clinical units and specialized diagnostic and research laboratories, building a multidisciplinary treatment system that integrates tumor surgery, precision radiotherapy and targeted chemotherapy. The institute's adoption of Edge Medical's platform validates the technology at one of the region's highest-tier clinical institutions.

"In the past, when people mentioned surgical robots, the first names that came to mind were European and American brands," said Edge Medical's Hungary partner. "Now, Edge Medical is changing that perception—they are bringing not just a new product, but a new possibility."

One Platform, Two Modalities

The MSP2000 is the world's first surgical-robot platform to integrate single-port and multi-port capabilities into a single system. Rather than requiring hospitals to purchase and maintain two separate devices, the platform combines the broad procedural versatility of multi-port robots with the ultra-minimally invasive approach, smaller incisions and faster recovery associated with single-port systems.

The integration represents more than a feature addition, according to the company—it is a redefinition of the underlying technical architecture for surgical robots. No comparable product form currently exists elsewhere in the global market.

Edge Medical received European Union CE certification under the Medical Device Regulation (MDR) framework in October 2025. The NIO installation is the first overseas deployment following that approval, moving the platform from regulatory clearance to active clinical practice on the international stage.

First Surgeries Under the Belt

Following installation, the MSP2000 has already been used to perform three multi-port robot-assisted surgeries at NIO. Dr. Dombovary led two robot-assisted radical prostatectomies for prostate cancer, while Dr. Kerepesi performed a total hysterectomy for endometrial cancer.

Both surgeons offered positive assessments of the system post-procedure, citing its operational precision, instrument flexibility and overall stability. They noted that the system's response was smooth and well-suited to the fine dissection demands of complex oncological surgery.

The successful multi-port cases also lay the groundwork for single-port applications at the institute. Notably, this installation marks the first time a single-port surgical-robot system has been introduced into Hungary's public healthcare system. When the single-port mode of the MSP2000 becomes operational, Hungarian patients will gain access to a less invasive surgical option—filling a longstanding gap in the country's public medical infrastructure.

A Regional Hub in the Making

Installation is only the beginning. NIO is set to become Central and Eastern Europe's first clinical demonstration and training center for integrated single-port/multi-port robotic surgery, conducting systematic technical training and clinical teaching programs.

Leveraging the institute's academic leadership and the MSP2000's technical capabilities, the center will serve as Edge Medical's base for demonstrating clinical value across the broader Central and Eastern European market. The goal: to translate advanced single-port and multi-port robotic surgery techniques into standardized procedures that regional surgeons can learn and adopt—driving wider adoption of minimally invasive surgery across the region.

For Edge Medical, the Hungary deployment is both a commercial milestone and a strategic statement. The company, which went public on the Hong Kong Stock Exchange main board, has been pursuing an aggressive internationalization strategy. The NIO installation—backed by CE certification and a first-of-its-kind product architecture—positions the Shenzhen-based company as a credible alternative in a market where Western brands have held sway for decades.